Physician

Adrian Crichton, O.D.

According to 2025 Medicare claims, Adrian Crichton, O.D. (NPI: 1073997052) practices optometrist in the Nassau County-Suffolk County, NY market, with the plurality of this provider's patient population coming from Nassau, NY. This provider's primary affiliated billing organization is OPHTHALMIC CONSULTANTS OF LONG ISLAND (NPI: 1285675660; TIN: 112498332) and primary practice location at 11554-1578. Crichton is affiliated with the Physician Leaders Direct Contracting Entity, LLC (ACO ID: D0171) and Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under the REACH model.

Crichton's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 168 traditional Medicare patients, billed 245 HCPCS/CPT codes, and received $19,885 in Medicare payments. The top billing code was 92004 (New patient complete exam of visual system). Part D data shows 107 prescription claims across 68 beneficiaries totaling $10,532 in drug costs, led by Neomycin-Polymyxin-Dexameth (Neomycin/Polymyxin B/Dexametha). Open Payments data shows 14 records totaling $561. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $895 and ending at $19,885. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,377 and ending at $10,532. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$27K$54K2016 Medicare payment: $895 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $7,154 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $38,190 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $54,458 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $38,759 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $48,888 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $42,309 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $19,885 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
20162222$895
20176794$7,154
2018339574$38,190
2019449821$54,458
2020352606$38,759
2021414739$48,888
2022381706$42,309
2023N/RN/RN/R
2024168245$19,885

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$15K$29K2017 Drug cost: $1,377 (USD; Tot_Drug_Cst)2018 Drug cost: $7,231 (USD; Tot_Drug_Cst)2019 Drug cost: $20,357 (USD; Tot_Drug_Cst)2020 Drug cost: $24,019 (USD; Tot_Drug_Cst)2021 Drug cost: $16,494 (USD; Tot_Drug_Cst)2022 Drug cost: $29,276 (USD; Tot_Drug_Cst)2023 Drug cost: $6,736 (USD; Tot_Drug_Cst)2024 Drug cost: $10,532 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
20171112$1,377
20182644$7,231
20193273$20,357
20203876$24,019
202163114$16,494
202254140$29,276
20231320$6,736
202468107$10,532

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92004New patient complete exam of visual system1818$123
92014Established patient complete exam of visual system2828$109
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more94101$82
92134Imaging of retina1212$36
92250Photography of the retina1616$33

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha44534$416
ErythromycinErythromycin Base1494$189

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.14$561BIOTISSUE HOLDINGS INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Adrian Crichton, O.D.?

Tedicare shows public-source Medicare data for Adrian Crichton, O.D. (NPI 1073997052), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adrian Crichton, O.D. have ACO affiliation data?

Adrian Crichton, O.D. is shown with ACO affiliation data for Physician Leaders Direct Contracting Entity, LLC (REACH, ACO ID D0171) and Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Adrian Crichton, O.D.?

Adrian Crichton, O.D. is linked to OPHTHALMIC CONSULTANTS OF LONG ISLAND (billing NPI 1285675660) in the available physician profile data.

Does Adrian Crichton, O.D. have Open Payments data?

Adrian Crichton, O.D. has 14 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.